期刊
MYCOSES
卷 58, 期 12, 页码 735-745出版社
WILEY
DOI: 10.1111/myc.12424
关键词
invasive fungal disease; multiplex fungal PCR; DNA-microarray; clinical samples
资金
- MSD
- German Federal Ministry of Research and Education (BMBF) [01KN1106]
- 3M
- Actelion
- Astellas
- AstraZeneca
- Basilea
- Bayer
- Celgene
- Cubist/Optimer
- Genzyme
- Gilead
- GSK
- Merck/MSD
- Miltenyi
- Pfizer
- Quintiles
- Shionogi
- Viropharma
- Schering-Plough
- Boehringer Ingelheim
- Novartis
- Roche
- Lilly
- Intermune
- Fresenius
- Essex
- Bracco
- MEDA Pharma
- Chiesi
- Siemens
- Covidien
- Pierre Fabre
- Grifols
- MeVis
- Merck
- Alexion
- MSD/Merck
- Gilead Sciences
- Merck Sharp Dohme/Merck
The increasing incidence of invasive fungal diseases (IFD), most of all invasive aspergillosis (IA) in immunocompromised patients emphasises the need to improve the diagnostic tools for detection of fungal pathogens. We investigated the diagnostic performance of a multifungal DNA-microarray detecting 15 different fungi [Aspergillus, Candida, Fusarium, Mucor, Rhizopus, Scedosporium and Trichosporon species (spp.)] in addition to an Aspergillus specific polymerase chain reaction (PCR) assay. Biopsies, bronchoalveolar lavage and peripheral blood samples of 133 immunocompromised patients (pts) were investigated by a multifungal DNA-microarray as well as a nested Aspergillus specific PCR assay. Patients had proven (n=18), probable (n=29), possible (n=48) and no IFD (n=38) and were mostly under antifungal therapy at the time of sampling. The results were compared to culture, histopathology, imaging and serology, respectively. For the non-Aspergillus IFD the microarray analysis yielded in all samples a sensitivity of 64% and a specificity of 80%. Best results for the detection of all IFD were achieved by combining DNA-microarray and Aspergillus specific PCR in biopsy samples (sensitivity 79%; specificity 71%). The molecular assays in combination identify genomic DNA of fungal pathogens and may improve identification of causative pathogens of IFD and help overcoming the diagnostic uncertainty of culture and/or histopathology findings, even during antifungal therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据